Healthcare provider profile · identity verified

Herbert Lempel, M.D.

Internal Medicine · FOREST HILLS, NY · NPI 1164423778

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	985	302
Amlodipine Besylate	Amlodipine Besylate	590	168
Losartan Potassium	Losartan Potassium	536	152
Rosuvastatin Calcium	Rosuvastatin Calcium	439	129
Hydrochlorothiazide	Hydrochlorothiazide	359	107
Levothyroxine Sodium	Levothyroxine Sodium	358	99
Metoprolol Succinate	Metoprolol Succinate	352	104
Tamsulosin Hcl	Tamsulosin Hcl	237	73
Pantoprazole Sodium	Pantoprazole Sodium	215	68
Simvastatin	Simvastatin	205	62
Lisinopril	Lisinopril	199	60
Metformin Hcl Er	Metformin Hcl	189	56
Finasteride	Finasteride	166	48
Atenolol	Atenolol	155	49
Fluticasone Propionate	Fluticasone Propionate	132	50
Escitalopram Oxalate	Escitalopram Oxalate	127	38
Omeprazole	Omeprazole	124	36
Ramipril	Ramipril	120	33
Mirtazapine	Mirtazapine	117	46
Synthroid	Levothyroxine Sodium	111	28
Albuterol Sulfate Hfa	Albuterol Sulfate	110	38
Gabapentin	Gabapentin	109	27
Ibandronate Sodium	Ibandronate Sodium	103	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	102	31
Alprazolam	Alprazolam	101	34
Metformin Hcl	Metformin Hcl	99	28
Eliquis	Apixaban	98	30
Jardiance	Empagliflozin	98	33
Ezetimibe	Ezetimibe	94	31
Zolpidem Tartrate	Zolpidem Tartrate	91	18
Metoprolol Tartrate	Metoprolol Tartrate	90	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	90	16
Montelukast Sodium	Montelukast Sodium	89	30
Sertraline Hcl	Sertraline Hcl	88	27
Furosemide	Furosemide	80	30
Azithromycin	Azithromycin	77	64
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	23
Allopurinol	Allopurinol	75	25
Meloxicam	Meloxicam	70	41
Alendronate Sodium	Alendronate Sodium	65	17
Clopidogrel	Clopidogrel Bisulfate	65	21
Clonazepam	Clonazepam	64	23
Duloxetine Hcl	Duloxetine Hcl	61	16
Famotidine	Famotidine	58	28
Ketoconazole	Ketoconazole	57	26
Ozempic	Semaglutide	57	16
Potassium Chloride	Potassium Chloride	56	18
Tramadol Hcl	Tramadol Hcl	52	19
Lorazepam	Lorazepam	48	suppressed
Diclofenac Sodium	Diclofenac Sodium	46	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Mounjaro	Tirzepatide	42	suppressed
Methylprednisolone	Methylprednisolone	41	31
Pregabalin	Pregabalin	41	suppressed
Valsartan	Valsartan	41	11
Januvia	Sitagliptin Phosphate	40	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	34
Spironolactone	Spironolactone	40	12
Carvedilol	Carvedilol	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	11
Pravastatin Sodium	Pravastatin Sodium	38	14
Mupirocin	Mupirocin	35	22
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Trazodone Hcl	Trazodone Hcl	34	11
Farxiga	Dapagliflozin Propanediol	33	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	32	suppressed
Lidocaine	Lidocaine	32	13
Meclizine Hcl	Meclizine Hcl	31	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	13
Diazepam	Diazepam	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Levofloxacin	Levofloxacin	22	16
Warfarin Sodium	Warfarin Sodium	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	15
Doxycycline Monohydrate	Doxycycline Monohydrate	20	11
Hydrocortisone	Hydrocortisone	20	suppressed
Methimazole	Methimazole	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	12
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Verapamil Er	Verapamil Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Amoxicillin	Amoxicillin	14	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lagevrio (Eua)	Molnupiravir	13	13
Mercaptopurine	Mercaptopurine	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Prolia	Denosumab	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Halobetasol Propionate	Halobetasol Propionate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Tobramycin	Tobramycin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error